Related Experiment Video
Updated: Aug 15, 2026
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 15, 2011
[The effect of recombinant interleukin-1 beta on concanavalin A-induced lymphocyte reactions]
Insights
Recombinant interleukin-1 beta enhances concanavalin A (ConA) responses in human lymphocytes and thymocytes. This cytokine boosts cell aggregation, chemiluminescence, and proliferation, indicating a priming effect on immune cell activation.
Area of Science:
- Immunology
- Cell Biology
Context:
- Investigating the role of cytokines in immune cell activation.
- Utilizing luminol-dependent chemiluminescence and light scattering for cellular analysis.
Purpose:
- To determine the effect of recombinant interleukin-1 beta on concanavalin A-induced responses in human lymphocytes and thymocytes.
- To elucidate the potentiating action of interleukin-1 beta on T-cell activation.
Summary:
- Addition of concanavalin A (ConA) to human peripheral blood lymphocytes, followed by incubation with recombinant interleukin-1 beta, significantly increased chemiluminescence and cell aggregation compared to controls.
- Recombinant interleukin-1 beta demonstrated a potentiating effect on the ConA-induced proliferative response of thymocytes in culture.
- The study discusses the mechanisms behind the priming action of recombinant interleukin-1 beta on ConA-induced lymphocyte reactions.
Impact:
- Provides insights into cytokine-mediated immune cell modulation.
- Highlights the synergistic effects of interleukin-1 beta and ConA on immune cell activation.
- Suggests potential therapeutic targets for modulating immune responses.
Abstract:
As revealed by investigations made by the use of the method of luminol-dependent chemiluminescence and light dispersion, the addition of concanavalin A (ConA) to the suspension of human peripheral blood lymphocytes and subsequent incubation with recombinant interleukin-1 beta leads to a sharp increase in the yield of chemiluminescence and the rate of cell aggregation in comparison with similar parameters obtained for cells, not treated with interleukin-1 beta. The study revealed the potentiating action of recombinant interleukin-1 beta on ConA-induced proliferative response of thymocytes in the culture. The mechanisms of the priming action of recombinant interleukin-1 beta on ConA-induced reaction of lymphocytes are discussed.
More Related Videos
06:29Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 2, 2011
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 31, 2013